france_ca49d06a08_14f8e2f33e.png
Trending News

100% French Stocks – February 6, 2026

Updated February 2026

PREOPEN CAC 40

8,220 points (-0.10%)


Key Stocks of the Day

Société Générale (GLE)

The bank posts a record annual profit and implements a generous shareholder return policy. Positive signal for financial strength and capital generation capacity.

Vinci (DG)

Very strong 2025 with a record free cash flow. High visibility in concessions and a favorable dynamic in construction.

Aperam (APAM)

The group is targeting an increase in Q1 2026 EBITDA, despite a decline year-on-year. Caution is advised regarding the expected rise in net debt linked to seasonal working capital needs.

Stellantis (STLAM)

Q4 2025 billings up +9% year-on-year, driven by North America (+43%). Europe remains under pressure with a decline of -4%.

Danone (BN)

Widening of infant milk recalls in France and Europe. Short-term reputation and media impact to monitor.

GTT (GTT)

Signed a contract for two LNG carrier tanks in China, strengthening the order book's visibility.

X-Fab (XFAB)

Q1 revenue target between $190–200 million. Automotive, industrial, and medical markets account for 94% of sales.

Coty

Slight increase in revenue but expected margin pressure in Q3 (-200 to -300 bps). Adjusted Q3 EBITDA expected between $100–110 million.


Today’s Earnings Calendar

  • Equasens
  • Guerbet
  • Akwel
  • Bassac
  • NRJ Group
  • Intrasense
  • Wallix

Analyst Recommendations

French companies only

Upgrades

  • BNP Paribas (BNP)
    Citi maintains Buy, target raised to €103
    UBS maintains Buy, target raised to €109
  • Vinci (DG)
    Jefferies maintains Buy, target raised from €138 to €143
  • Rexel (RXL)
    Citi maintains Buy, target raised from €38 to €43
  • Soitec (SOI)
    Deutsche Bank maintains Buy, target raised from €40 to €44

Neutral

  • Air France-KLM (AF)
    Oddo BHF maintains Neutral, target raised from €12 to €14
  • Gecina (GFC)
    Citi maintains Buy, target slightly lowered from €122 to €118
  • Sartorius Stedim Biotech (DIM)
    Nephron Research maintains Buy, target adjusted to €247

Watchlist

  • Danone (BN)

Negative short-term news due to product recalls, with no change in recommendation at this time.


Have a great session, everyone!
Sylvain Mouilhaud – Stock Coach

Back to Ouinex Blog